Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Colorectal Neoplasms 3 Glioblastoma 2 Vulvar Neoplasms 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplastic Cells, Circulating 1 Neoplasm, Residual 1 Muscle Invasive Bladder Urothelial Carcinoma 1 Melanoma 1 Locally Advanced Rectal Carcinoma 1 Hypoxia 1 Gliosarcoma 1 Glioma 1 Genetic Diseases, Inborn 1 Esophageal Neoplasms 1 Circulating Tumor DNA 1 Carcinoma, Non-Small-Cell Lung 1 Biliary Tract Neoplasms 1 Astrocytoma 1

Interventions

Temozolomide 115 Radiotherapy 63 Magnetic Resonance Spectroscopy 30 Carboplatin 30 Bevacizumab 30 Carmustine 28 Filgrastim 23 Surgical Procedures, Operative 22 Irinotecan 22 Radiation 18 Lomustine 17 Vincristine 15 Etoposide 15 Specimen Handling 13 Peripheral Blood Stem Cell Transplantation 13 O(6)-benzylguanine 13 Radiotherapy, Intensity-Modulated 12 Procarbazine 11 Erlotinib Hydrochloride 11 Cyclophosphamide 11 Chemotherapy, Adjuvant 11 sargramostim 10 Thiotepa 10 Cisplatin 10 Flucytosine 9 Everolimus 9 antineoplaston AS 2-1 8 antineoplaston A10 8 Granulocyte Colony-Stimulating Factor 8 Vorinostat 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Astrocytoma × Circulating Tumor DNA × Clear all

NCT03973918 2024-10-31

BRAF

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Terminated

5 enrolled 15 charts

Astrocytoma, Glioblastoma, Glioma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡